Abstract
OBJECTIVE: To report rates of cost-related skipping of medications and other treatments, assess correlates of skipping, examine changes in skipping between 1998 and 2000, and identify factors associated with changes in skipping.
DESIGN, SETTING, AND PARTICIPANTS: Cross-sectional and longitudinal analyses of surveys of a probability sample of Medicare beneficiaries in 13 states in 1998 and 2000.
MAIN OUTCOME MEASURE: Self-reported rates of skipping medications and other treatments.
RESULTS: Cost-related skipping rates increased from 9.5% in 1998 to 13.1% in 2000. In separate multivariable models using 1998 and 2000 data, higher out-of-pocket costs, lower physician-patient relationship quality, low income, and lacking prescription drug coverage were associated with more skipping (P<.05 for all). Better physical and mental health, and greater age were associated with less skipping (P<.05). HMO membership was not associated with higher rates of skipping in 1998 (P=.84), but was in 2000 (P<.0004). In longitudinal analyses, increased medication costs and HMO membership were associated with the observed increase cost-related skipping between 1998 and 2000.
CONCLUSIONS: Cost-related skipping was associated with several factors, including drug coverage, poverty, poor health, and physician-patient relationship quality. The important role of physician-patient relationships in cost-related skipping has not been shown previously. Physicians should be aware of these risk factors for cost-related skipping, and initiate dialogue about problems paying for prescription medications and other treatments.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Myers LB, Midence K. Concepts and issues in adherence. In: Myers LB, Midence K, eds. Adherence to Treatment in Medical Conditions. Amsterdam: Harwood Academic Publishers; 1998:1–24.
Shumaker SA, Schron EB, Ockene JK, McBee WL, eds. The Handbook of Health Behavior Change. 2nd ed. New York: Springer Publishing Company, Inc.; 1998.
Haynes RB. Strategies to improve compliance with referrals, appointments, and prescribed medical regimens. In: Haynes RB, Taylor DW, Sackett DL, eds. Compliance in Health Care. Baltimore, Md: The Johns Hopkins University Press; 1979:121–43.
Poisal JA, Murray L. Growing differences between Medicare beneficiaries with and without drug coverage. Health Aff (Millwood). 2001;20:74–85.
Stuart B, Grana J. Ability to pay and the decision to medicate. Med Care. 1998;36:202–11.
Blustein J. Drug coverage and drug purchases by Medicare beneficiaries with hypertension. Health Aff (Millwood). 2000;19:219–30.
Adams AS, Soumerai SB, Ross-Degnan D. Use of antihypertensive drugs by Medicare enrollees: does type of drug coverage matter? Health Aff (Millwood). 2001;20:276–86.
Lillard LA, Rogowski J, Kington R. Insurance coverage for prescription drugs: effects on use and expenditures in the Medicare population. Med Care. 1999;37:926–36.
Department of Health & Human Services. Report to the President: Prescrition Drug Coverage, Spending, Utilization, and Prices. 2000. http://www.aspe.hhs.gov/health/reports/drugstudy.
Mojtabai R, Olfson M. Medication costs, adherence, and health outcomes among Medicare beneficiaries. Health Aff (Millwood). 2003;22:220–9.
Heisler M, Langa KM, Eby EL, Fendrick AM, Kabeto MU, Piette JD. The health effects of restricting prescription medication use because of cost. Med Care. 2004;42:626–34.
Piette JD, Heisler M, Wagner TH. Cost-related medication underuse among chronically ill adults: the treatments people forgo, how often, and who is at risk. Am J Public Health. 2004;94:1782–7.
Safran DG, Neuman P, Schoen C, et al. Prescription drug coverage and seniors: how well are states closing the gap. Health Aff (Millwood). 2002;W253–67.
Steinman MA, Sands LP, Covinsky KE. Self-restriction of medications due to cost in seniors without prescription coverage. J Gen Intern Med. 2001;16:793–9.
Safran DG, Wilson IB, Rogers WH, Montgomery JE, Chang H. Primary care quality in the Medicare Program: comparing the performance of Medicare health maintenance organizations and traditional fee-for-service medicare. Arch Intern Med. 2002;162:757–65.
Dillman DA. Mail and Telephone Surveys: the Total Design Method. New York, NY: John Wiley & Sons; 1978.
Aday LA, Andersen R. Development of Indices of Access to Medical Care. Ann Arbor, Mich: Health Administration Press; 1975.
Andersen RM. A Behavioral Model of Families’ Use of Health Services, Research Series No. 25. Chicago, Ill: Center for Health Administration Studies, University of Chicago; 1968.
Safran DG, Kosinski M, Tarlov AR, et al. The primary care assessment survey: tests of data quality and measurement performance. Med Care. 1998;36:728–39.
Murphy J, Chang H, Montgomery JE, Rogers WH, Safran DG. The quality of physician-patient relationships. Patients’ experiences 1996–1999. J Fam Pract. 2001;50:123–9.
National Center for Health Statistics. Current Estimates from the National Health Interview Survey. Washington, DC: U.S. Government; 1993.
McHorney CA, Ware JEJ, Raczek AE. The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care. 1993;31:247–63.
Jones MP. Indicator and stratification methods for missing explanatory variables in multiple linear regression. J Am Stat Assoc. 1996;91:222–30.
Greene WH. Econometric Analysis 1993. New York, NY: Macmillan Publishing Company; 1993.
Safran DG. Defining the future of primary care: what can we learn from patients? Ann Intern Med. 2003;138:248–55.
Report to the Congress: Selected Medicare Issues. Washington, DC: Medicare Payment Advisory Commission; 2000.
Pear R. 17 percent increase in prescription drug costs hit elderly hardest, study finds. The New York Times. June 27, 2002.
Strunk BC, Ginsburg PB, Gabel JR. Tracking health care costs. Health Aff (Millwood). 2002;(suppl):W39–50.
Connolly C. Pharmaceutical spending continues stady increase: a few heavily advertised and high-priced “blockbuster” medications drive 17 percent increase. Washington Post. March 29, 2002:09.
Achman L, Gold M. Trends in Medicare+Choice: Benefits and Premiums, 1999–2002. New York, NY: The Commonwealth Fund; 2002.
Alexander GC, Casalino LP, Meltzer DO. Patient-physician communication about out-of-pocket costs. JAMA. 2003;290:953–8.
Piette JD, Heisler M, Wagner TH. Cost-related medication underuse: do patients with chronic illnesses tell their doctors? Arch Intern Med. 2004;164:1749–55.
Maxwell S, Baseggio C. Outpatient Therapy Services Under Medicare: Background and Policy Issues. Washington, DC: The Urban Institute; 2000.
Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). ALLHAT Collaborative Research Group. JAMA. 2002;288:2981–97.
Author information
Authors and Affiliations
Corresponding author
Additional information
This research was supported by grant number R01 HS09622 from the Agency for Healthcare Research and Quality and the National Institute on Aging.
Rights and permissions
About this article
Cite this article
Wilson, I.B., Rogers, W.H., Chang, H. et al. Cost-related skipping of medications and other treatments among medicare beneficiaries between 1998 and 2000. J Gen Intern Med 20, 715–720 (2005). https://doi.org/10.1111/j.1525-1497.2005.0128.x
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1111/j.1525-1497.2005.0128.x